The key observations of both this study and similar projects are (1) many high-risk females in Canada do not receive the dedicated specialty care required to prevent cancers and improve outcomes, and (2) the current family-history-based testing strategy to identify females with a BRCA1/2 PV misses a significant proportion of those at very high cancer risk. Here, BRCA1 is linked to cancer.